Target intelligence / Profile preview

Bone Tissue with Altered Osteogenesis

Molecular classification
Extracellular Matrix, Structural Protein, Signaling Pathway Component
01

Overview

Bone tissue with altered osteogenesis refers to bone in which the normal process of bone formation (osteogenesis) is disrupted or abnormal. Alterations can result from genetic mutations, changes in extracellular matrix composition, mechanical factors, or disruptions in cellular signaling pathways, leading to conditions like osteogenesis imperfecta and osteoporosis. Key features include defects in type I collagen synthesis, impaired osteoblast function, altered ECM composition, and dysregulation of signaling pathways such as BMP and TGF-β. Mechanical factors, genetic mutations in genes like COL1A1/COL1A2, and cellular stress responses contribute to altered osteogenesis.

Other names
Defective Bone FormationAbnormal OsteogenesisImpaired Bone DevelopmentOsteogenesis imperfectaOsteoporosis
02

Mechanism of action

Bisphosphonates: Inhibit osteoclast activity. Teriparatide: Stimulates osteoblast activity. Romosozumab: Sclerostin inhibitor, increases bone formation.

03

Biological functions

Bone FormationSkeletal DevelopmentMechanotransductionMineralizationStructural Support
04

Disease associations

OsteoporosisOsteogenesis ImperfectaSkeletal DysplasiaBone FractureImpaired Fracture Healing
05

Safety considerations

Bisphosphonates: Osteonecrosis of the jaw, atypical femoral fractures.Teriparatide: Osteosarcoma (potential risk).Romosozumab: Cardiovascular events.
06

Interacting drugs

Bisphosphonates

2 more in the full profile.

07

Biomarkers

Type I Collagen Propeptides (PINP, CTX)Bone Mineral Density (BMD)DMP1MEPE

Beyond the preview

Go deeper on Bone Tissue with Altered Osteogenesis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone Tissue with Altered Osteogenesis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call